Literature DB >> 9326323

The molecular pathology of progressive symmetric erythrokeratoderma: a frameshift mutation in the loricrin gene and perturbations in the cornified cell envelope.

A Ishida-Yamamoto1, J A McGrath, H Lam, H Iizuka, R A Friedman, A M Christiano.   

Abstract

The erythrokeratodermas (EKs) are a group of disorders characterized by erythematous plaques associated with variable features that include palmoplantar keratoderma. One type of EK is known as "progressive symmetric erythrokeratoderma" (PSEK). We studied members of a family of Japanese origin in which the index case with PSEK had had well-demarcated nonmigratory erythematous plaques on her extremities since birth. Sequence determination of the loricrin gene revealed an insertion of a C following nucleotide 709. The mutation results in a frameshift that changes the terminal 91 amino acids in the wild-type polypeptide into missense amino acids and adds 65 additional residues. This further implicates loricrin defects in the pathogenesis of disorders with palmoplantar keratoderma and pseudoainhum.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9326323      PMCID: PMC1715943          DOI: 10.1086/515518

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  32 in total

1.  Progressive symmetric erythrokeratodermia.

Authors:  M Nir; F Tanzer
Journal:  Dermatologica       Date:  1978

2.  Progressive symmetric erythrokeratodermia.

Authors:  L C Gray; L S Davis; M A Guill
Journal:  J Am Acad Dermatol       Date:  1996-05       Impact factor: 11.527

3.  Topology prediction for helical transmembrane proteins at 86% accuracy.

Authors:  B Rost; P Fariselli; R Casadio
Journal:  Protein Sci       Date:  1996-08       Impact factor: 6.725

4.  A molecular defect in loricrin, the major component of the cornified cell envelope, underlies Vohwinkel's syndrome.

Authors:  E Maestrini; A P Monaco; J A McGrath; A Ishida-Yamamoto; C Camisa; A Hovnanian; D E Weeks; M Lathrop; J Uitto; A M Christiano
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

Review 5.  Frontiers in keratodermas: pushing the envelope.

Authors:  A M Christiano
Journal:  Trends Genet       Date:  1997-06       Impact factor: 11.639

Review 6.  Empirical predictions of protein conformation.

Authors:  P Y Chou; G D Fasman
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

7.  Erythrokeratodermia congenitalis progressiva symmetrica (Gottron). II. An analysis of kinetics of epidermal cell proliferation.

Authors:  V K Hopsu-Havu; P Tuohimaa
Journal:  Dermatologica       Date:  1971

8.  Erythrokeratodermia congenitalis progressiva symmetrica (Gottron).

Authors:  V K Hopsu-Havu; L Peltonen
Journal:  Dermatologica       Date:  1970

9.  Erythrokeratodermia progressiva symmetrica: report of 10 cases.

Authors:  R Ruiz-Maldonado; L Tamayo; V del Castillo; I Lozoya
Journal:  Dermatologica       Date:  1982-02

10.  Erythrokeratodermia variabilis. Report of three cases and review of the literature.

Authors:  J Brown; R R Kierland
Journal:  Arch Dermatol       Date:  1966-02
View more
  19 in total

Review 1.  Connexin mutations in skin disease and hearing loss.

Authors:  D P Kelsell; W L Di; M J Houseman
Journal:  Am J Hum Genet       Date:  2001-01-25       Impact factor: 11.025

2.  [Progressive symmetric erythrokeratodermia of Darier-Gottron].

Authors:  H Ott; S Lehmann; P Poblete-Gutiérrez; J Frank
Journal:  Hautarzt       Date:  2004-10       Impact factor: 0.751

3.  Progressive symmetrical erythrokeratoderma - response to topical calcipotriol.

Authors:  Ilgül Bilgin; Kübra Eren Bozdağ; Seçil Uysal; Murat Ermete
Journal:  J Dermatol Case Rep       Date:  2011-09-21

4.  Identification of human epidermal differentiation complex (EDC)-encoded genes by subtractive hybridization of entire YACs to a gridded keratinocyte cDNA library.

Authors:  I Marenholz; M Zirra; D F Fischer; C Backendorf; A Ziegler; D Mischke
Journal:  Genome Res       Date:  2001-03       Impact factor: 9.043

5.  Activation of vascular endothelial growth factor receptor 2 in a cellular model of loricrin keratoderma.

Authors:  Kozo Yoneda; Toshio Demitsu; Kozo Nakai; Tetsuya Moriue; Wataru Ogawa; Junsuke Igarashi; Hiroaki Kosaka; Yasuo Kubota
Journal:  J Biol Chem       Date:  2010-03-17       Impact factor: 5.157

6.  Local burn injury impairs epithelial permeability and antimicrobial peptide barrier function in distal unburned skin.

Authors:  Jennifer K Plichta; Steve Droho; Brenda J Curtis; Parita Patel; Richard L Gamelli; Katherine A Radek
Journal:  Crit Care Med       Date:  2014-06       Impact factor: 7.598

7.  Gene targeting of envoplakin, a cytoskeletal linker protein and precursor of the epidermal cornified envelope.

Authors:  A Määttä; T DiColandrea; K Groot; F M Watt
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

8.  TRPV3 mutants causing Olmsted Syndrome induce impaired cell adhesion and nonfunctional lysosomes.

Authors:  Manoj Yadav; Chandan Goswami
Journal:  Channels (Austin)       Date:  2016-10-18       Impact factor: 2.581

9.  Suppressing AP1 factor signaling in the suprabasal epidermis produces a keratoderma phenotype.

Authors:  Ellen A Rorke; Gautam Adhikary; Christina A Young; Dennis R Roop; Richard L Eckert
Journal:  J Invest Dermatol       Date:  2014-08-22       Impact factor: 8.551

10.  Nicotinic acetylcholine receptor stimulation impairs epidermal permeability barrier function and recovery and modulates cornified envelope proteins.

Authors:  Brenda J Curtis; Jennifer K Plichta; Hanz Blatt; Steven Droho; Tina M Griffin; Katherine A Radek
Journal:  Life Sci       Date:  2012-08-22       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.